NCT00132912View on ClinicalTrials.gov

Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573)

PHASE2CompletedINTERVENTIONAL

Enrollment

1,030

Participants

Timeline

Start Date

August 30, 2005

Primary Completion Date

January 28, 2007

Study Completion Date

January 28, 2007

Conditions

Arterial Obstructive DiseasesCoronary Disease

Interventions

DRUG

SCH 530348

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00132912 - Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573) | Biotech Hunter | Biotech Hunter